UniProt Q5T440
Putative transferase CAF17, mitochondrial (Q5T440)
Putative transferase CAF17, mitochondrial (UniProt Q5T440), EC 2.1.-.-: 6 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound, 10 pockets. Binding sites, druggability and experiment against prediction…
- UniProt
- Q5T440
- Protein
- Putative transferase CAF17, mitochondrial
- EC
- 2.1.-.-
- Experimental structures
- 6
- Predicted models
- 1
- Ligands
- 1
- Pockets
- 10 · 1 record with a druggable one
Structures
7 records of Q5T440 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 6GEU | Crystal structure of the C230A mutant of human IBA57 | x-ray diffraction | A | — | 3 (best 0.53) |
| 6GEU | Crystal structure of the C230A mutant of human IBA57 | x-ray diffraction | A | — | — |
| 6QE3 | Re-refinement of 6ESR human IBA57 at 1.75 A resolution | x-ray diffraction | A | — | 4 (best 0.47) |
| 6QE3 | Re-refinement of 6ESR human IBA57 at 1.75 a resolution | x-ray diffraction | A | — | — |
| 6QE4 | Re-refinement of 5OLI human IBA57-I3C | x-ray diffraction | A | I3C | 3 (best 0.42) |
| 6QE4 | Re-refinement of 5OLI human IBA57-I3C | x-ray diffraction | A | I3C | — |
| Q5T440 | AlphaFold monomer V2.0 prediction for putative transferase CAF17, mitochondrial (Q5T440) | predicted | A | — | — |
Ligands
- I3C · 5-amino-2,4,6-triiodobenzene-1,3-dicarboxylic acid · in 2 records
Experiment against prediction
- 6GEU chain A against the predicted model Q5T440: TM-score 0.98, RMSD 1.08 Å
- 6GEU chain A against the predicted model Q5T440: TM-score 0.98, RMSD 1.08 Å
- 6QE4 chain A against the predicted model Q5T440: TM-score 0.98, RMSD 1.13 Å
- 6QE4 chain A against the predicted model Q5T440: TM-score 0.98, RMSD 1.13 Å
- 6QE3 chain A against the predicted model Q5T440: TM-score 0.97, RMSD 1.31 Å
- 6QE3 chain A against the predicted model Q5T440: TM-score 0.97, RMSD 1.31 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.